Jaana Rysä
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Pharmacology top 2%
- Apelin-related biomedical research
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cardiac Fibrosis and Remodeling 26
- Cardiac Valve Diseases and Treatments 10
- Cardiovascular Function and Risk Factors 9
- Co-authors
- Heikki RuskoahoMika IlvesHanna LeskinenJukka HakkolaHeikki TokolaJanne HukkanenSampsa PikkarainenIstván Szokodi
In The Last Decade
Jaana Rysä
105 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cardiology and Cardiovascular Medicine 857
- Pharmacology 519
- Endocrinology, Diabetes and Metabolism 341
- Cellular and Molecular Neuroscience 336
- Pharmacology 155
Countries citing papers authored by Jaana Rysä
This map shows the geographic impact of Jaana Rysä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaana Rysä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaana Rysä more than expected).
Fields of papers citing papers by Jaana Rysä
This network shows the impact of papers produced by Jaana Rysä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaana Rysä. The network helps show where Jaana Rysä may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jaana Rysä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 46 | |
| 12 | 2022 | 6 | |
| 13 | Pregnane X receptor‒4β‐hydroxycholesterol axis in the regulation of overweight‐ and obesity‐induced hypertension | 2022 | 7 |
| 14 | 2020 | 10 | |
| 15 | 2019 | 4 | |
| 16 | 2018 | 30 | |
| 17 | 2018 | 12 | |
| 18 | 2013 | 37 | |
| 19 | 2008 | 13 | |
| 20 | 2007 | 41 |
About Jaana Rysä
Jaana Rysä is a scholar working on Cardiology and Cardiovascular Medicine, Biological Psychiatry, Pharmacology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 113 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (26 papers), Signaling Pathways in Disease (13 papers), Hormonal Regulation and Hypertension (12 papers), Cardiac Valve Diseases and Treatments (10 papers), Cardiovascular Function and Risk Factors (9 papers), Congenital heart defects research (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Protease and Inhibitor Mechanisms (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (857 citations), Pharmacology (519 citations), Endocrinology, Diabetes and Metabolism (341 citations), Cellular and Molecular Neuroscience (336 citations) and Pharmacology (155 citations). Jaana Rysä has collaborated with scholars based in Finland, Sweden and Hungary. Frequent co-authors include Heikki Ruskoaho, Mika Ilves, Hanna Leskinen, Jukka Hakkola, Heikki Tokola, Janne Hukkanen, Sampsa Pikkarainen, István Szokodi, Jarkko Piuhola and Pasi Tavi. Their work appears in journals such as Basic & Clinical Pharmacology & Toxicology, Scientific Reports, Blood Pressure, PLoS ONE and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.